Consider the following facts: KP has spent $ 1000 on research and development (R&D) and FDA testing for Corzine. The Corzine project will require building a new manufacturing plant. KP purchased a plot of land 5 years ago for $500. The land was recently appraised at Sl 000. If KP rejects the Corzine project they will sell the land since it will not be needed. KP will spend S8000 to build the plant. The new plant will be depreciated down to zero on a straight-line basis, over the project's 5 year useful life. KP will need to increase Net Working Capital (NWC) by $1000 at time zero. NWC will then decrease by $200 each year of the project 's life, so that after year 5 the NWC is completely recovered. The fixed assets associated with the project will have no salvage value. KP will need to spend $500 at time 5 to clean up hazardous waste from the plant. The $500 is a tax-deductible expense. KP spent $500 on a marketing study that resulted in this sales forecast for the quantity sold each year: Year Units sold 2 3 4 5 800 900 1100 1000 950 Corzine will sell for SIO/unit, with variable costs of 50% of sales. Fixed costs associated with the Corzine project will be $1500 per year. Adopting the Corzine project will cause sales ofKP's existing drug Wellmax to fall by 200 units per year. Wellmax sells for $8/unit with variable costs of 40% of sales. Recall that KP's tax rate is 24%.